Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...

Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva, in the UK for the treatment of chronic obstructive ...

There is weak evidence from case series that oral glycopyrronium bromide tablets reduce sweating in people with hyperhidrosis. The most commonly reported adverse effects are antimuscarinic, ...

QUEBEC CITY, July 11, 2023 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) announced on May 26, 2023, that its Canada subsidiary, Lupin Pharma Canada Ltd., has received approval from Health ...

"There is significant opportunity in the inhalers market and we believe that this deal will give further impetus to Glenmark's growth in Europe," he added. "There is significant opportunity in the ...

Glenmark Pharmaceuticals Europe has entered into a strategic, exclusive licensing agreement for marketing generic Tiotropium Bromide dry powder inhaler, used in the treatment of chronic obstructive ...

MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.